- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02291003
Identification of Novel Circadian Biomarkers
Study Overview
Status
Conditions
Detailed Description
Circadian clocks are not only found in discrete areas of the brain, but are found in virtually every organ in our bodies, including the heart, lungs and immune system. Disruptions in circadian clocks, or chronopathology, may underlie various forms of cardiovascular, pulmonary, and metabolic disorders. Over the past two decades, molecular geneticists have "cracked" the clock to reveal its core biochemical mechanisms evident in organisms from fruit flies to humans. These mechanistic insights have led to the discovery of links between clock function and an ever-expanding array of prevalent diseases, including heart, lung, metabolic and sleep disorders. Yet the prevalence of circadian disruption in these patient populations is unclear because current tests are not easily applied in clinical settings or have yet to be developed. Perhaps the major limitation of these techniques is the need for serial sampling over extended periods of at least 24 hours and in some cases longer. The development of an assay from a single blood draw would represent a major step forward, facilitating assessments of circadian disruption in a range of diseases.
An alternative strategy to existing assays is to use genomic microarrays to analyze circadian rhythms. Many studies in a number of organisms as well as multiple organs and tissues have found that substantial fractions of the genome (2-10%) are under robust circadian clock control. Importantly, these hundreds of rhythmic genes exhibit expression peaks at all times throughout the day, presumably reflecting their time-of-day specific functions. Using this as a foundation, Ueda and colleagues proposed an alternative strategy that would allow assessment of circadian time from a single blood draw allowing more routine assessments of circadian clock state. In brief, they identified the complement of rhythmic genes in livers of mice. They then selected a set of approximately 50 genes with unique peak times as "time-indicating genes." They then assessed the transcript levels of these time-indicating genes at a single time of day and found that they could accurately determine the time of day that the liver was taken based on the relative expression levels of the time-indicating genes. These studies provide proof-of-principle for the approach that we propose here. Establishing a molecular assay in humans for circadian rhythms from a single time point will allow us to identify circadian rhythm disorders, and to assess internal biological time to deliver therapies at their most efficacious time.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Illinois
-
Chicago, Illinois, United States, 60611
- Northwestern University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Healthy controls
- Age 18-60
- Intermediate circadian chronotype as determined by the Horne-Ostberg and Munich questionnaire
- Habitual sleep start times between 9:30pm and 1am
- Habitual sleep duration of 6-9 hours
Exclusion Criteria:
- History or current Diagnostic and Statistical Manual-V major psychiatric disorder
- Use of psychoactive medications
- Beck Depression inventory ≥ 16 indicating possible depression
- A history or current diagnosis of a primary sleep disorder (insomnia, sleep apnea, circadian rhythm sleep disorder, restless legs)
- Shift work or other types of self-imposed irregular sleep/wake cycles
- History of, or concurrent unstable or serious medical illness
- Allergy to heparin
- Blindness or other visual impairment other than glasses
Study Plan
How is the study designed?
Design Details
- Observational Models: Other
- Time Perspectives: Other
Cohorts and Interventions
Group / Cohort |
---|
Healthy controls
Healthy controls -observational, no intervention administered.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Circadian gene expression profile
Time Frame: 1 day
|
The circadian pattern of gene expression will be determined through collecting saliva and blood at regular intervals over a 24 hour and analyzing with microarrays.
|
1 day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Phyllis C Zee, MD, PhD, Northwestern University
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- STU00096215
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Circadian Rhythm Disorders
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingSleep | Sleep Disturbance | Anesthesia | Sleep Disorders, Circadian Rhythm | Circadian Rhythm Sleep Disorder | Circadian Rhythm Disorder Caused by Drug | Circadian Rhythm Sleep Disorder, Jet Lag Type | Jet LagNetherlands
-
Brigham and Women's HospitalNSBRICompletedCircadian RhythmUnited States
-
Vanda PharmaceuticalsCompletedCircadian Rhythm Sleep DisordersUnited States
-
Taipei Veterans General Hospital, TaiwanNational Yang Ming UniversityRecruitingShift Work Type Circadian Rhythm Sleep DisorderTaiwan
-
Brigham and Women's HospitalNational Center for Complementary and Integrative Health (NCCIH)Completed
-
Yale UniversityCompletedCircadian Rhythm Sleep Disorder, UnspecifiedUnited States
-
Columbia UniversityRecruitingEating Behavior | Shift Work Type Circadian Rhythm Sleep DisorderUnited States
-
Federal University of UberlandiaCompletedShift Work Type Circadian Rhythm Sleep DisorderBrazil
-
University of Alabama at BirminghamAmerican Heart AssociationCompletedBlood Pressure | Circadian RhythmUnited States
-
Samsung Medical CenterCompletedCircadian Rhythm Phase Shift